About Spect Pharma Private Limited
Data last updated:
Spect Pharma Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2017PTC034167. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Arun Kumar and Shisham Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor Commercial House Kankarbagh Main Road, Patna, Bihar, India – 800020.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.22 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹33,498 (net margin -5.4%) and EBITDA of ₹71,256 (EBITDA margin 11.5%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spectpharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address2nd Floor Commercial House Kankarbagh Main Road, Patna, Bihar, India – 800020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Spect Pharma Private Limited
The main business activity of Spect Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Spect Pharma Private Limited FY 2025 filings available
Spect Pharma Private Limited reported revenue of ₹6.22 Lakh (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Spect Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 51% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spect Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71,256 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹33,498 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Spect Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spect Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Spect Pharma Private Limited
Spect Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tryin Merchants Private Limited | ₹6.23 Lakh (FY 2024) | •••• | •••• | -65.0% | •••• | Ranchi, Jharkhand, India |
| Blueland Vanijya Private Limited | ₹6.23 Lakh (FY 2024) | •••• | •••• | 63.0% | •••• | Kolkata, West Bengal, India |
| Qualigrafe Author Services Private Limited | ₹6.22 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Coimbatore, Tamil Nadu, India |
| Tadem's Therapeutics and Pharma Solutions Private Limited | ₹6.22 Lakh (FY 2018) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Almoramart Private Limited | ₹6.22 Lakh (FY 2022) | •••• | •••• | •••• | Ramapuram, Kerala, India | |
| Spect Pharma Private Limited this company | ₹6.22 Lakh (FY 2025) | •••• | •••• | -51.0% | •••• | Patna, Bihar, India |
| SSB Global Business Associates Private Limited | ₹6.22 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Rohtak, Haryana, India |
| Victory Homes Private Limited | ₹6.22 Lakh (FY 2024) | •••• | •••• | -76.0% | •••• | Chennai, Tamil Nadu, India |
| Bhikshu Enterprises Private Limited | ₹6.22 Lakh (FY 2025) | •••• | •••• | 280.0% | •••• | New Delhi, Delhi, India |
| Gurukripa Reality Private Limited | ₹6.21 Lakh (FY 2024) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Paradise Wardrobe Private Limited | ₹6.21 Lakh (FY 2019) | •••• | •••• | 1854.0% | •••• | Bijhar, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Spect Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Spect Pharma Private Limited
Spect Pharma Private Limited is audited by VIVEKANAND ASHISH PRANAY & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIVEKANAND ASHISH PRANAY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Spect Pharma Private Limited
Spect Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar | Director | 30 Mar 2017 | 9 Years 6 Months | Current |
| Shisham Sharma | Director | 30 Mar 2017 | 9 Years 6 Months | Current |
Ownership and Shareholding of Spect Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spect Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2021 | Indian Bank | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Spect Pharma Private Limited
Employment history and EPFO contributions of people linked to Spect Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Spect Pharma Private Limited
Spect Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Amrita Kumari ceased to be Director on 02 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Spect Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spect Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spect Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Spect Pharma Private Limited
Spect Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spect Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spect Pharma Private Limited
Spect Pharma is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 March 2017 (9+ years old) and is registered under CIN U74999BR2017PTC034167.
Spect Pharma reported revenue of ₹6.22 Lakh for FY 2025 (down 51% YoY).
Spect Pharma has 2 current directors:
- Arun Kumar - Director
- Shisham Sharma - Director
Spect Pharma reported a net loss of ₹33,498 (net margin -5.4%) and EBITDA of ₹71,256 (EBITDA margin 11.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Spect Pharma is -8% over three years and -22% over five years. In the latest year (FY 2025) revenue fell 51%. CAGR is the steady yearly rate that links the first and the last year.
No. Spect Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Spect Pharma is U74999BR2017PTC034167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spect Pharma was incorporated on 30 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Spect Pharma by revenue are Tryin Merchants Private Limited, Blueland Vanijya Private Limited, Qualigrafe Author Services Private Limited, Tadem's Therapeutics and Pharma Solutions Private Limited, Almoramart Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Amrita Kumari ceased to be Director on 02 Dec 2022. Arun Kumar was appointed as Director on 30 Mar 2017. Shisham Sharma was appointed as Director on 30 Mar 2017.
Spect Pharma can be reached through the website spectpharma.co.in. Its registered office is in Patna, Bihar, India.